Vicore Pharma Holding AB Share Price
NASDAQ: VCRE$0.00
+0.00 (0.00%) Vicore Pharma Holding AB Stock Performance
Vicore Pharma Holding AB Share Price Chart
$0.00$0.00
L
H
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Vicore Pharma Holding AB Historical Returns
| Month | Open | Close | Change % |
|---|